Concludingan agreement with a transaction advisor_#160;Withreference to ESPI Report 22/2022 of 7 September 2022, the ExecutiveBoard of Genomtec S.A. ("Company", "Issuer") registered in Wroclaw,Poland, hereby reports that on 30 November 2022, Company signed anagreement with Clairfield Partners LLC, headquartered in New York (the_quot;Advisor_quot;, Clairfield), to provide advisory services in connection withthe planned partnership, license, and / or sale of part or all of itsintellectual property and related technology.